US Stock Market Move | ZYBT.US, a biological company, entered the US stock market and saw a 22% surge in its opening price.

On Tuesday, Chinese animal vaccine supplier ZYBT.US made its debut on the US stock market, soaring more than 22% to $4.88 at the time of writing. The company has offered 1.5 million shares at an initial public offering price of $4 per share. Established in 2004, ZYBT.US focuses on research, development, manufacturing, and sales of animal vaccines, with a focus on livestock vaccines. Its product portfolio currently includes 43 animal vaccines, covering all major vaccines for pigs and cattle, and is also developing vaccines for domestic animals such as dogs. The company's products are sold in 29 provinces in China and exported to overseas countries such as Vietnam, Pakistan, and Egypt. Data shows that the company had sales of $29 million in the 12 months ending on December 31, 2023.